 | • レポートコード：B-MOR-05084 • 出版社/出版日：Mordor Intelligence / 2018年3月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、肥満手術用デバイスの世界市場について調べ、肥満手術用デバイスの世界規模、市場動向、市場環境、デバイスタイプ別分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・肥満手術用デバイスの世界市場インサイト ・肥満手術用デバイスの世界市場環境 ・肥満手術用デバイスの世界市場動向 ・肥満手術用デバイスの世界市場規模 ・肥満手術用デバイスの世界市場規模：デバイスタイプ別 ・肥満手術用デバイスの世界市場規模：エンドユーザー別 ・肥満手術用デバイスの世界市場：地域別市場規模・分析 ・肥満手術用デバイスの北米市場規模・予測 ・肥満手術用デバイスのアメリカ市場規模・予測 ・肥満手術用デバイスのヨーロッパ市場規模・予測 ・肥満手術用デバイスのアジア市場規模・予測 ・肥満手術用デバイスの日本市場規模・予測 ・肥満手術用デバイスの中国市場規模・予測 ・肥満手術用デバイスのインド市場規模・予測 ・肥満手術用デバイスの韓国市場規模・予測 ・関連企業情報・競争状況 |
The global bariatric surgery devices market is expected to register a CAGR of 9.5% during the forecast period, 2018 to 2023. Bariatric surgery is mainly used to reduce body weight. Bariatric surgical procedures are carried out for the treatment of a comorbid condition, which is associated with morbid obesity requires bariatric surgery devices.
Increase in Obese Population
According to World Health Organisation (WHO), in 2016, more than 1.9 billion adults, 18 years and older, were overweight; of these over 650 million were obese. This means that about one-third of the overall global population is overweight; this is fueled by urbanization, poor diets, and lack of physical activity. Among all the countries, the United States has the large percentage of obese children and young adults, around 13%. As the prevalence of obesity is increasing worldwide, the overall bariatric surgeries are expected to increase, which will directly propel the bariatric surgery devices market. The other factors, such as the prevalence of diabetes, insurance coverage for the surgeries, and government initiatives, are driving the market.
High Cost of Surgery
The high cost of the surgery is due to pre- and post-surgery fees. Cost depends on the surgery type, which may range between USD 15,000-35,000. The most expensive among the surgeries is the duodenal switch surgery, which costs about USD 27,000. The gastric sleeve surgery, which is highly recommended, costs about USD 19,000. Insurance companies cover only a portion of these expenses. The huge cost associated with the surgeries will restrain the growth of the market. Along with these, other factors, such as lack of awareness in developing countries and lower disposable incomes in developing countries, are hindering the growth of the market for bariatric surgery devices.
North America to Dominate the Market
North America dominates the market for bariatric surgery devices as the people in the region have higher disposable incomes when compared to other regions, especially as these bariatric surgery procedures are expensive. In terms of revenue, the European bariatric surgery market follows that of North America.
Key Developments in the Market
• November 2017: Apollo Endosurgery received FDA Clearance for OverStitch Sx Endoscopic Suturing System.
• August 2017: As per FDA, five deaths were reported while using weight loss balloon treatment.
Major Players: APOLLO ENDOSURGERY INC., ETHICON INC., TRANSENTERIX INC., ALLERGAN, INC., JOHNSON & JOHNSON, RESHAPE MEDICAL, INC., COVIDIEN PLC, ENTEROMEDICS, INC., AND ASPIRE BARIATRICS INC., amongst others.
Reasons to Purchase the Report
• Current and future bariatric surgery devices market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increase in Obese Population
6.1.2 Prevalence of Diabetes and Heart Diseases
6.1.3 Government Initiatives to Curb Obesity
6.1.4 Insurance Coverage of the Surgeries
6.2 Market Restraints
6.2.1 Lack of Knowledge and Awareness in Developing and Underdeveloped Countries
6.2.2 High Cost of surgery
6.2.3 Lower Disposable Incomes in Developing and Underdeveloped Nations
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Device
7.1.1 Assisting Devices
7.1.1.1 Suturing Device
7.1.1.2 Closure Device
7.1.1.3 Stapling Device
7.1.1.4 Trocars
7.1.1.5 Clip Appliers
7.1.1.6 Others
7.1.2 Implantable Devices
7.1.2.1 Gastric Bands
7.1.2.2 Electrical Stimulation Devices
7.1.2.3 Gastric Balloons
7.1.2.4 Gastric Emptying
7.2 By End User
7.2.1 Bariatric Surgery Clinics
7.2.2 Hospitals
7.2.3 Ambulatory Surgical Centers
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United Kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 China
7.3.3.2 Japan
7.3.3.3 India
7.3.3.4 Australia & New Zealand
7.3.3.5 South Korea
7.3.3.6 Rest of Asia-Pacific
7.3.4 Middle East & Africa
7.3.4.1 GCC
7.3.4.2 South Africa
7.3.4.3 Rest of the Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Apollo Endosurgery Inc.
9.2 Ethicon Inc.
9.3 TransEnterix Inc.
9.4 Allergan, Inc.
9.5 ReShape Medical, Inc.
9.6 Covidien Plc
9.7 EnteroMedics, Inc.
9.8 Aspire Bariatrics Inc.
9.9 Others
10. Future of the Market